Le Lézard
Classified in: Health
Subject: EGV

The European Society of Endocrinology Meets With European Parliament Members to Discuss Limiting the Socioeconomic Impact of Osteoporosis in Europe


MILAN, October 18, 2018 /PRNewswire/ --

In Brussels, the European Society of Endocrinology has met 10 European Parliament members and proposed a shared agenda to limit the socioeconomic impact of Osteoporosis in Europe.

Tackling hypovitaminosis D, early diagnosis of vertebral fractures, access and adherence to therapies are the key points to work on.

     (Logo: https://mma.prnewswire.com/media/770911/The_European_Society_of_Endocrinology_Logo.jpg )

Affecting more than half of population aged over 80, osteoporosis represents an emergency in terms of social relevance and economic - healthcare costs.  The European Society of Endocrinology seizes the opportunity of the World Osteoporosis Day to meet European Authorities and set forth a proposal of shared healthcare policies that may produce large-scale benefits and improve people's health and State budgets.

 

"Fragility fractures have an important economic impact.  The direct costs (hospitalizations) only in Italy account for around 9 billion euros. 1 more billion of indirect costs, such as rehabilitation costs and losses due to absence from work, has to be added. We find the same situation in the rest of EU States as well - says Prof. Andrea Giustina, Professor of Endocrinology at San Raffaele Hospital in Milan and President-Elect of the European Society of Endocrinology - The three-point document we will set forth to the EP members proposes some cost-effective measures of clinical practice aimed at limiting costs and drastically reducing the incidence of this disease."

The document prepared by the ESE is set out in 3 points:


"European endocrinologists wish that this agenda of intervention might gain the widest consent among Institutions and are ready to help in order to find in practice the most effective instruments to implement intervention on the mentioned criticalities. They also commit themselves to verify the execution and effectiveness of said instruments 12 months hence," concludes Giustina.


These press releases may also interest you

at 14:24
Evermore Cannabis Company, a leader in innovative cannabis cultivation and product development, is thrilled to announce its remarkable success at the first-ever Maryland Leaf Bowl, held on April 13th. Demonstrating excellence across multiple...

at 14:23
Autolomous, the market-leading developer of critical manufacturing management systems for cell and gene therapies, and BioCentriq, industry-leading clinical-phase Cell Therapy CDMO (contract development and manufacturing organization), announce a...

at 14:15
As patients with congenital heart diseases live longer, researchers are attempting to understand some of the other complications they may face as they age. In a new study, a team from Children's Hospital of Philadelphia (CHOP) used state-of-the-art...

at 14:08
Seacoast Laboratory Data Systems, a nationwide leader in providing customizable LIS and AR software solutions for commercial and...

at 14:05
The Atrium at Cardinal Drive, a Benchmark Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Massachusetts and the entire U.S. for the second straight year. In U.S. News & World Report's third...

at 14:04
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) is proud to announce the recipients of the 2024 ADLM and Academy of Diagnostics & Laboratory Medicine Awards. Through this annual awards program, ADLM and its Academy...



News published on and distributed by: